Zoran Filipovic
- Molecular Biology top 2%
- Oncology top 0.5%
- Cancer Research top 2%
- Organic Chemistry top 5%
- Biotechnology top 1%
- Co-authors
- Lyubomir T. VassilevBinh Thanh VuBradford GravesFrank PodlaskiEmily A. LiuNader FotouhiChristian KleinNorman Kong
- Topics
- Cancer-related Molecular Pathways (10 papers)Ubiquitin and proteasome pathways (6 papers)Microtubule and mitosis dynamics (4 papers)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Zoran Filipovic
16 papers receiving 5.2k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Molecular Biology 3.9k
- Oncology 3.2k
- Cancer Research 695
- Organic Chemistry 608
- Biotechnology 510
Countries citing papers authored by Zoran Filipovic
This map shows the geographic impact of Zoran Filipovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zoran Filipovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zoran Filipovic more than expected).
Fields of papers citing papers by Zoran Filipovic
This network shows the impact of papers produced by Zoran Filipovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zoran Filipovic. The network helps show where Zoran Filipovic may publish in the future.
Co-authorship network of co-authors of Zoran Filipovic
This figure shows the co-authorship network connecting the top 25 collaborators of Zoran Filipovic. A scholar is included among the top collaborators of Zoran Filipovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zoran Filipovic. Zoran Filipovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 3 | |
| 4 | 6 | |
| 5 | 4 | |
| 6 | 50 | |
| 7 | 42 | |
| 8 | 220 | |
| 9 | Discovery of RG7388, a Potent and Selective p53–MDM2 Inhibitor in Clinical Developmentbreakdown → | 447 |
| 10 | 3 | |
| 11 | 68 | |
| 12 | 1 | |
| 13 | Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: Implications for therapybreakdown → | 553 |
| 14 | In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2breakdown → | 3722 |
| 15 | Macrophage inhibitory cytokine-1: a novel biomarker for p53 pathway activation. | 141 |
| 16 | 12 | |
| 17 | 24 |
About Zoran Filipovic
Zoran Filipovic is a scholar working on Oncology, Cell Biology and Molecular Biology, having authored 17 papers that have together received 5.3k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (10 papers), Ubiquitin and proteasome pathways (6 papers) and Microtubule and mitosis dynamics (4 papers). The work is most often cited by research in Oncology (3.2k citations), Biotechnology (510 citations) and Molecular Biology (3.9k citations). Zoran Filipovic has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Lyubomir T. Vassilev, Binh Thanh Vu, Bradford Graves, Frank Podlaski, Emily A. Liu, Nader Fotouhi, Christian Klein, Norman Kong, Christine Lukacs and U. Kammlott. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.